Skip to Main Content

Paper Details

Single institution long-term efficacy and safety analysis of abiraterone acetate (AA) in the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) in a named patient programme (NPP).
ESMO Open
2
2016
Author NameAffiliation
Jure MurgicUniversity Hospital Center Sestre Milosrdnice
  • 1 - 1

Datasets

Release 1.2